EmergentMedTech is proud to announce its merger with TRU Biologix, a transformative step in expanding its portfolio of biologics and advancing the field of regenerative medicine. With TRU Biologix now part of the EmergentMedTech family, the company is excited to deliver cutting-edge cell and tissue products, alongside other regenerative solutions, to clients and partners. The addition of TRU Biologix products marks a milestone in EmergentMedTech’s commitment to providing innovative solutions for researchers and clinicians.
Read the full article: TRU Biologix Merges with EmergentMedTech to Expand Offerings in Regenerative Medicine //
Source: https://www.prnewswire.com/news-releases/tru-biologix-merges-with-emergentmedtech-to-expand-offerings-in-regenerative-medicine-302357768.html